Order Article Reprints

Li H-P, Huang C-Y, Lui K-W, Chao Y-K, Yeh C-N, Lee L-Y, Huang Y, Lin T-L, Kuo Y-C, Huang M-Y, et al. Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment. Cancers. 2021; 13(12):2954. https://doi.org/10.3390/cancers13122954

Li, Hsin-Pai, Chen-Yang Huang, Kar-Wai Lui, Yin-Kai Chao, Chun-Nan Yeh, Li-Yu Lee, Yenlin Huang, Tung-Liang Lin, Yung-Chia Kuo, Mei-Yuan Huang, and et al. 2021. "Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment" Cancers 13, no. 12: 2954. https://doi.org/10.3390/cancers13122954

Li, H.-P., Huang, C.-Y., Lui, K.-W., Chao, Y.-K., Yeh, C.-N., Lee, L.-Y., Huang, Y., Lin, T.-L., Kuo, Y.-C., Huang, M.-Y., Lai, Y.-R., Yeh, Y.-M., Fan, H.-C., Lin, A.-C., Hsieh, J. C.-H., Chang, K.-P., Lin, C.-Y., Wang, H.-M., Chang, Y.-S., & Hsu, C.-L. (2021). Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment. Cancers, 13(12), 2954. https://doi.org/10.3390/cancers13122954